• Je něco špatně v tomto záznamu ?

Cost of skeletal complications from bone metastases in six European countries

J. Pereira, JJ. Body, O. Gunther, H. Sleeboom, G. Hechmati, N. Maniadakis, E. Terpos, YP. Acklin, J. Finek, R. von Moos,

. 2016 ; 19 (6) : 611-8. [pub] 20160223

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17024170

Objective Patients with bone metastases or lesions secondary to solid tumors or multiple myeloma often experience bone complications (skeletal-related events [SREs]-radiation to bone, pathologic fracture, surgery to bone, and spinal cord compression); however, recent data that can be used to assess the value of treatments to prevent SREs across European countries are limited. This study aimed to provide estimates of health resource utilization (HRU) and cost associated with all SRE types in Europe. HRU data were reported previously; cost data are reported herein. Methods Eligible patients from 49 centers across Austria (n = 57), the Czech Republic (n = 59), Finland (n = 60), Greece (n = 59), Portugal (n = 59), and Sweden (n = 62) had bone metastases or lesions secondary to breast, lung, or prostate cancer, or multiple myeloma, and ≥1 index SRE (a SRE preceded by a SRE-free period of ≥ 6.5 months). SRE-related costs were estimated from a payer perspective using health resource utilization data from patient charts (before and after the index SRE diagnosis). Country-specific unit costs were from 2010 and local currencies were converted to 2010 euros. Results The mean costs across countries were €7043, €5242, €11,101, and €11,509 per radiation to bone, pathologic fracture, surgery to bone, and spinal cord compression event, respectively. Purchasing power parity (PPP)-adjusted mean cost ratios were similar in most countries, with the exception of radiation to bone. Limitations The overall burden of SREs may have been under-estimated owing to home visits and evaluations outside the hospital setting not being reported here. Conclusions All SREs were associated with substantial costs. Variation in SRE-associated costs between countries was most likely driven by differences in treatment practices and unit costs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17024170
003      
CZ-PrNML
005      
20171208111458.0
007      
ta
008      
170720s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.3111/13696998.2016.1150852 $2 doi
035    __
$a (PubMed)26849381
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Pereira, J $u a Universidade NOVA de Lisboa, National School of Public Health, Public Health Research Centre (CISP) , Lisbon , Portugal ;
245    10
$a Cost of skeletal complications from bone metastases in six European countries / $c J. Pereira, JJ. Body, O. Gunther, H. Sleeboom, G. Hechmati, N. Maniadakis, E. Terpos, YP. Acklin, J. Finek, R. von Moos,
520    9_
$a Objective Patients with bone metastases or lesions secondary to solid tumors or multiple myeloma often experience bone complications (skeletal-related events [SREs]-radiation to bone, pathologic fracture, surgery to bone, and spinal cord compression); however, recent data that can be used to assess the value of treatments to prevent SREs across European countries are limited. This study aimed to provide estimates of health resource utilization (HRU) and cost associated with all SRE types in Europe. HRU data were reported previously; cost data are reported herein. Methods Eligible patients from 49 centers across Austria (n = 57), the Czech Republic (n = 59), Finland (n = 60), Greece (n = 59), Portugal (n = 59), and Sweden (n = 62) had bone metastases or lesions secondary to breast, lung, or prostate cancer, or multiple myeloma, and ≥1 index SRE (a SRE preceded by a SRE-free period of ≥ 6.5 months). SRE-related costs were estimated from a payer perspective using health resource utilization data from patient charts (before and after the index SRE diagnosis). Country-specific unit costs were from 2010 and local currencies were converted to 2010 euros. Results The mean costs across countries were €7043, €5242, €11,101, and €11,509 per radiation to bone, pathologic fracture, surgery to bone, and spinal cord compression event, respectively. Purchasing power parity (PPP)-adjusted mean cost ratios were similar in most countries, with the exception of radiation to bone. Limitations The overall burden of SREs may have been under-estimated owing to home visits and evaluations outside the hospital setting not being reported here. Conclusions All SREs were associated with substantial costs. Variation in SRE-associated costs between countries was most likely driven by differences in treatment practices and unit costs.
650    _2
$a senioři $7 D000368
650    _2
$a nádory kostí $x komplikace $x ekonomika $x sekundární $7 D001859
650    _2
$a Evropa $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fraktury spontánní $x ekonomika $x etiologie $7 D005598
650    _2
$a výdaje na zdravotnictví $x statistika a číselné údaje $7 D005102
650    _2
$a zdravotnické služby $x ekonomika $x využití $7 D006296
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a ekonometrické modely $7 D017059
650    _2
$a komprese míchy $x ekonomika $x etiologie $7 D013117
655    _2
$a časopisecké články $7 D016428
700    1_
$a Body, J-J $u b C.H.U. Brugmann, Université Libre de Bruxelles , Brussels , Belgium ;
700    1_
$a Gunther, O $u c Centre for Observational Research, Amgen Ltd , Uxbridge , UK ;
700    1_
$a Sleeboom, H $u d HAGA Hospital , The Hague , The Netherlands ;
700    1_
$a Hechmati, G $u e Health Economics, Amgen (Europe) GmbH , Zug , Switzerland ;
700    1_
$a Maniadakis, N $u f Department of Health Services Management , National School of Public Health , Athens , Greece ;
700    1_
$a Terpos, E $u g University of Athens School of Medicine, Alexandra University Hospital , Athens , Greece ;
700    1_
$a Acklin, Y P $u h Kantonsspital Graubünden , Chur , Switzerland ; $7 gn_A_00001030
700    1_
$a Finek, J $u i University Hospital , Plzen , Czech Republic ;
700    1_
$a von Moos, R $u j Kantonsspital Graubünden , Chur , Switzerland.
773    0_
$w MED00193522 $t Journal of medical economics $x 1941-837X $g Roč. 19, č. 6 (2016), s. 611-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26849381 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20171208111639 $b ABA008
999    __
$a ok $b bmc $g 1239851 $s 985083
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 19 $c 6 $d 611-8 $e 20160223 $i 1941-837X $m Journal of medical economics $n J Med Econ $x MED00193522
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Možnosti archivace